Mytos is building a fully-automated cell manufacture platform for Pharma
Mytos has raised $19.0M in total funding. The most recent round was Series A. The last funding was announced in November 2023.
Mytos's investors include Y Combinator, Wing Venture Capital, IQ Capital, Buckley Ventures, Acequia Capital (AceCap).
Mytos is headquartered in London, United Kingdom.
Mytos is building a fully-automated cell manufacture platform for Pharma
Mytos is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mytos — Funding & Investors." VCBacked, November 30, 2023, https://www.vcbacked.co/company/mytos. Accessed July 21, 2026.
VCBacked. (2023). Mytos — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/mytos
{{cite web |title=Mytos — Funding & Investors |url=https://www.vcbacked.co/company/mytos |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated